Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04644237
Title Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) (DESTINY-LUNG02)
Acronym DESTINY-LUNG02
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Daiichi Sankyo, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of Colorado Denver - Anschutz Medical Campus Aurora Colorado 80045 United States Details
AdventHealth Orlando Orlando Florida 32803 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Norton Cancer Institute Louisville Kentucky 40241 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Cancer Institute/Henry Ford Hospital Detroit Michigan 48202 United States Details
University of Michigan Detroit Michigan 48202 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Virgina Cancer Specialists Fairfax Virginia 22031 United States Details
St John of God Subiaco Hospital Subiaco 6008 Australia Details
Princess Alexandra Hospital Woolloongabba 4102 Australia Details
University Health Network Toronto M5G0A3 Canada Details
Centre Leon Berard Lyon 69008 France Details
Assistance Publique Hopitaux de Marseille AP-HM, Hopital NORD Marseille 13015 France Details
Hopital Pontchaillou Rennes 35000 France Details
CHU Nantes Saint-Herblain 44800 France Details
CHU toulouse - hôpital Larrey Toulouse 31059 France Details
Gustav Roussy Villejuif 94800 France Details
Ospedale San Luca Lucca 55100 Italy Details
IRCCS Istituto Europeo di Oncologia Milano 20141 Italy Details
SC Oncologia, AOU Policlinico Modena Modena 41124 Italy Details
Istituto Nazionale Tumori Fondazione G. Pascale di Napoli Strutturadi Oncologia Napoli 80131 Italy Details
Azienda Ospedaliero-Universitaria San Luigi Gonzaga Orbassano 10043 Italy Details
Humanitas Cancer Center Istituto Clinico Humanitas Rozzano 20089 Italy Details
Aichi Cancer Center Hospital Chikusa 464-8681 Japan Details
National Cancer Central Hospital Chuo Ku 104-0045 Japan Details
National Hospital Organization Kyushu Cancer Center Fukuoka 11111 Japan Details
National Cancer Center Hospital East Kashiwa 277-0882 Japan Details
Okayama University Hospital Okayama 700-8558 Japan Details
Kindai University Hospital Ōsaka-sayama 589-8511 Japan Details
Chungbuk National University Hospital Chungbuk 28644 Korea, Republic of Details
Seoul National University Bundang Hospital Seongnam 463-707 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Asan Medical Center Seoul 3080 Korea, Republic of Details
Samsung Medical Center Seoul 6351 Korea, Republic of Details
Netherlands Cancer Institute Amsterdam 1066CX Netherlands Details
Erasmus MC Rotterdam 3015 GD Netherlands Details
Hospital Universitario Vall d'Hebron Barcelona 08023 Spain Details
Clinica Universidad de Navarra Madrid 28027 Spain Details
Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital 12 de Octubre Madrid 28041 Spain Details
Hospital Universitari i Politècnic La Fe Valencia 46026 Spain Details
Chung Shan Medical University Hospital Taichung 40705 Taiwan Details
Taichung Veterans General Hospital Taichung 40705 Taiwan Details
National Cheng Kung University Hospital NCKUH Tainan 704 Taiwan Details
National Taiwan University Hospital Taipei City 10002 Taiwan Details
Chang Gung Memorial Hospital CGMH - LinKou Branch Taoyuan 333 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field